Create a free research account to view current pricing and place an order.
How does Semaglutide work in research models?
Semaglutide is a long-acting GLP-1 receptor agonist. GLP-1 receptor activation enhances glucose-dependent insulin secretion, suppresses glucagon release, delays gastric emptying, and engages central appetite-regulation pathways within the hypothalamus and brainstem.
What is the half-life of Semaglutide?
Half-life: Approx. 1 week.
Approximate half-life is about 1 week. Peak concentration is typically reached 1-3 days after subcutaneous administration, and steady state is generally approached after 4-5 weeks of once-weekly use.
Research dosing reference
0.25-2.4 mg once weekly; escalate only after GI tolerance is established.
Dose interpretation (U-100 units)
| Target dose | U-100 units |
|---|---|
| 0.25 mg | 5 units |
| 0.50 mg | 10 units |
| 1.00 mg | 20 units |
| 2.40 mg | 48 units |
Units are concentration-specific - confirm against your actual reconstitution volume.
How is Semaglutide reconstituted?
| Vial | Preferred reconstitution | Final concentration |
|---|---|---|
| 10 mg | 2 mL BAC Water | 0.050 mg/unit |
Injection timing
Once weekly on a consistent day. Time of day is less important than consistency; choose timing that minimizes nausea disruption.
Beginner escalation
Start at the lowest practical exposure and hold each step long enough to evaluate GI tolerance before increasing.
Side-effect mitigation
Monitor nausea, reflux, constipation, reduced appetite, hydration status, fatigue, and delayed gastric emptying. Slow escalation and hydration/electrolytes are primary mitigation tools.
Stack compatibility
Avoid stacking overlapping incretin agonists unless intentionally structured and clinician supervised. Pathway contrast with GH-axis, mitochondrial, or lipolysis adjuncts is generally cleaner than incretin overlap.
Storage & stability
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically.
Protocol duration & reassessment
Long-term metabolic protocols should include reassessment every 8-12 weeks: GI tolerance, hydration, appetite adaptation, body-composition response, metabolic markers, and whether escalation is still needed. Avoid continuous escalation without objective review.
Frequently asked questions
What is Semaglutide and how is it studied?
Semaglutide is a long-acting GLP-1 receptor agonist. GLP-1 receptor activation enhances glucose-dependent insulin secretion, suppresses glucagon release, delays gastric emptying, and engages central appetite-regulation pathways within the hypothalamus and brainstem. Semaglutide is catalogued in the GLP / Metabolic group of this reference and is studied in laboratory and in-vitro models only.
What is known about the half-life of Semaglutide?
Reference half-life for Semaglutide: approx. 1 week. Approximate half-life is about 1 week. Published pharmacokinetic figures come from research and clinical-literature contexts and are listed here as reference values for laboratory work only, not as guidance for any person or animal.
How is Semaglutide stored?
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically. Lyophilized research peptides are generally kept cold, dry, and away from light, and reconstituted solutions are labeled with concentration and date. Follow the storage conditions documented for the specific lot you receive.
How is Semaglutide reconstituted for laboratory work?
The reference reconstitution for the 10 mg vial is 2 mL BAC Water, which gives a concentration of about 5 mg/mL. Concentration equals peptide mass divided by diluent volume, so adding more liquid lowers the concentration. Add diluent slowly down the vial wall, swirl rather than shake, and confirm the arithmetic before preparing any research solution.
Is Semaglutide FDA approved?
No. The research-grade Semaglutide described here is an investigational, research-use-only material and is not an FDA-approved drug product. Where an approved pharmaceutical form of a compound exists, it is a separate prescription product. This reference is not medical advice, and the material is not for human or animal consumption.
Semaglutide product overview · Semaglutide cost · All research reference · Research guides
External references: Peptide (Wikipedia) · U.S. Food and Drug Administration